CCCC - C4 Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$7.00
DETAILS
HIGH:
$7.00
LOW:
$7.00
MEDIAN:
$7.00
CONSENSUS:
$7.00
UPSIDE:
96.63%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 77.8% |
| EBIT Margin | -291.7% |
| EBITDA Margin | -286.3% |
| Operating Margin | -290.7% |
| Pretax Margin | -291.7% |
| Cont. Ops Margin | -292.1% |
| Net Margin | -292.1% |
| Bottom Line Margin | -292.1% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 7.81 |
| Quick Ratio | 7.81 |
| Solvency Ratio | -1.005 |
| Cash Ratio | 2.26 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-1.51
Peers avg: 28.5
|
| PEG Ratio | 0.09 |
| Forward PEG | 0.09 |
| Price/Book | 0.62 |
| Price/Sales | 4.40 |
| Price/FCF | -1.59 |
| Price/Op Cash Flow | -1.60 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.1670 |
| Debt/Equity | 0.2338 |
| Debt/Capital | 0.1895 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.40 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.16 |
| Operating Cash Flow Ratio | -2.988 |
| Operating Cash Flow/Sales | -274.6% |
| Free Cash Flow/Operating Cash Flow | 100.6% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -16.18 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -15.50 |
| Operating Cash Flow Coverage | -1.65 |
| Capital Expenditure Coverage | -162.59 |
| Dividend + Capital Expenditure Coverage | -162.59 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.43 |
| EPS | -1.267 |
| Debt/Share | 0.7236 |
| Cash/Share | 3.00 |
| Book Value/Share | 3.10 |
| Tangible BV/Share | 3.10 |
| Equity/Share | 3.10 |
| Operating Cash Flow/Share | -1.191 |
| Capital Expenditure/Share | 0.007 |
| FCF/Share | -1.198 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.001 |
| Earnings Before Tax/EBIT | 1.004 |
| Price/Fair Value | 0.62 |
| Debt/Market Cap | 0.0402 |
| Effective Tax Rate | -0.1% |
| Enterprise Value Multiple | -1.40 |